The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

artaxbiopharma.com

Executives

6

Board of Directors

1

Artax Biopharma Board of Director

1 Board of directors

Artax Biopharma has 1 board of directors, including Alan Walts.

Name

Firm

Work History

Other Seats

Alan Walts

Dr. Walts is a Board Observer and Advisor to Amylyx. Alan has broad experience in the Life Science industry and serves as Executive Chairman of Aura Biosciences, Executive Chairman of Artax Biopharma, as a Director of X4 Pharmaceuticals and as a Director of Arrakis Therapeutics. Alan was a Business Advisor to the late Henri Termeer, and worked closely with Henri on founding and investing in early-stage companies. Alan is also a US-based Venture Partner with Advent Life Sciences. Alan has over 25 years of industry experience in venture capital, business development, research and development, and general management at Genzyme Corporation. Prior to leaving Genzyme in 2013, Alan managed Genzyme’s corporate venture fund, Genzyme Ventures (now Sanofi-Genzyme BioVentures). Alan received a Ph.D. in chemistry from MIT in 1985, carried out post-doctoral research in biochemistry at MIT with Professor Christopher Walsh, and completed the Executive Program for Management Development at Harvard Business School.

Artax Biopharma

Name

Alan Walts

Firm

Work History

Dr. Walts is a Board Observer and Advisor to Amylyx. Alan has broad experience in the Life Science industry and serves as Executive Chairman of Aura Biosciences, Executive Chairman of Artax Biopharma, as a Director of X4 Pharmaceuticals and as a Director of Arrakis Therapeutics. Alan was a Business Advisor to the late Henri Termeer, and worked closely with Henri on founding and investing in early-stage companies. Alan is also a US-based Venture Partner with Advent Life Sciences. Alan has over 25 years of industry experience in venture capital, business development, research and development, and general management at Genzyme Corporation. Prior to leaving Genzyme in 2013, Alan managed Genzyme’s corporate venture fund, Genzyme Ventures (now Sanofi-Genzyme BioVentures). Alan received a Ph.D. in chemistry from MIT in 1985, carried out post-doctoral research in biochemistry at MIT with Professor Christopher Walsh, and completed the Executive Program for Management Development at Harvard Business School.

Other Seats

Artax Biopharma

Artax Biopharma Management Team

6 Team Members

Artax Biopharma has 6 executives. Artax Biopharma's founder is Damia Tormo. Artax Biopharma's current Chief Executive Officer is Joseph M. Lobacki.

Name

Work History

Title

Status

Damia Tormo

Founder

Current

Joseph M. Lobacki

Chief Executive Officer

Current

Andrés Gagete Mateos

Chief Operating Officer

Current

Richard Polisson

Chief Medical Officer

Current

Victor Vercher

Touchlight AAV, Columbus Venture Partners, DiningIn, Suffolk University, and Root Capital

Chief Financial Officer

Former

Name

Damia Tormo

Joseph M. Lobacki

Andrés Gagete Mateos

Richard Polisson

Victor Vercher

Work History

Touchlight AAV, Columbus Venture Partners, DiningIn, Suffolk University, and Root Capital

Title

Founder

Chief Executive Officer

Chief Operating Officer

Chief Medical Officer

Chief Financial Officer

Status

Current

Current

Current

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.